Using Amyloid Precursor Protein (APP) transgenic mice, we observed that chronic intraperitoneal (i.p.)injection of AD animals with both amylin and its analog, pramlintide, reduce the amyloid burden as well as lowers the concentrations of Aβ and improve learning and memory [13]. Here, APP is linked to Alzheimer disease.